Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
No Image
|
Fig. 8D
Flach H et al. (2022)
|
Xla Wt + glyphosate [121.5]
NF37/38 (in situ hybridization)
|
|
|
No Image
|
Fig. 8D
Flach H et al. (2022)
|
Xla Wt + glyphosate [243]
NF43 (immunohistochemistry) [tnnt2]
|
|
|
|
Fig.3.C
Pokrovsky D et al. (2021)
|
Xla Wt + hydroxyurea + aphidicolin
NF32 (in situ hybridization)
|
|
|
|
Fig.1 CD
Afouda BA et al. (2018)
|
Xla.Tg(myl2:GFP)Mohun + gata4 MO + Activin + explant
NF32 (RT-PCR)
|
|
|
|
Fig. 1 CD
Afouda BA et al. (2018)
|
Xla.Tg(myl2:GFP)Mohun + gata5 MO + Activin + explant
NF32 (RT-PCR)
|
|
|
|
Fig. 1 CD
Afouda BA et al. (2018)
|
Xla.Tg(myl2:GFP)Mohun + gata6 MO + Activin + explant
NF32 (RT-PCR)
|
|
|
|
Fig. 2 B
Afouda BA et al. (2018)
|
Xla.Tg(myl2:GFP)Mohun + sox18 MO + Activin + explant
NF32 (RT-PCR)
|
|
|
|
Fig2 A
Afouda BA et al. (2018)
|
Xla.Tg(myl2:GFP)Mohun + sox7 MO + Activin + explant
NF32 (RT-PCR)
|
|
|
|
Fig 5B,C
Shifley ET et al. (2012)
|
Xla Wt + PD173074
NF35/36 (in situ hybridization)
|
|
|
|
Fig 5B,C
Shifley ET et al. (2012)
|
Xla Wt + PD173074
NF35/36 (in situ hybridization)
|
|
|